AnCan frequently recommends second opinions on prostate cancer and genitourinary (GU) pathology slides – whether it be from biopsy, surgery or another protocol. Our recommended providers are:
Active Surveillance Prostate Cancer Video Chat, May 13th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Eric- Atlanta 8:29 PM
BPH ASPI video Dr. Casey Dauw: https://aspatients.org/meeting/the-abcs-of-bph/
Eric- Atlanta 8:30 PM
Ancan Special Presentation: It Ain’t Your Grandpa’s BPH: https://ancan.org/special-presentation-it-aint-your-grandpas-bph/
Andy Douglas, FL 8:40 PM
Standard Medicare Coverage Criteria (all must be met) Medicare covers Aquablation once per patient when: prostate volume is 30–150 cc confirmed by transrectal ultrasound (TRUS), IPSS score greater than or equal to 12, maximum urinary flow rate less than or equal to15 mL/s with voided volume greater than 125 cc, and there has been failure or intolerance of at least 3 months of conventional therapy (such as alpha-blockers or 5-ARIs). The procedure must use an FDA-approved device
Rob Wood 8:42 PM
Rob Wood – Maine– aquablation questions to Mike Williams woodsinmaine@gmail.com
BJ Kap 8:59 PM
thanks guys great discussion have a good night
Eric- Atlanta 9:10 PM
Benign Prostatic Hypertrophy (BPH) Morgan McDowell, DNP, APRN, WHNP-BC, AGPCNP-BC: https://grandroundsinurology.com/benign-prostatic-hypertrophy-bph/?_hsmi=381422106&fbclid=IwZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHicfwgnaFklEBjKzeyZafooENJ-llAD_2V-GZKdLpAKoPZvT4jXRibNOyO-y_aem_x0ohp35PKH7dhukcwFD2Tg
Mike Thompson 9:15 PM
Thanks everyone- great discussion tonight. Good night.
Prostate Cancer Focal Therapy as Primary Treatment
Many Gents and their Carers visit our Low/Intermediate Prostate Cancer Group with the intention of using focal therapy to treat their situation. They believe this minimizes treatment and side effects.
AnCan has never been a huge fan of any form of focal therapy. We strongly hold that it is not needed or appropriate for GG1 (Gleason 3+3) men. If elected, it is largely for men with GG2 (G3+4) and on rare occasions GG3 (G4+3).
A major concern with focal therapy is the high rate of recurrence, no matter the type of focal treatment.. Invariably it is over 50%. Since many trials and practitioners treat men with 3+3 disease with some success, the true rate of failure for men with GG2 and GG3 may be considerably higher.
In the UCSF Patient Conference on Prostate Cancer ( April 17, 2026), Dr. Matt Cooperberg presented the following slide that guides AnCan Moderators:
(apologies for clarity… from a screenshot)
Please note AnCan does not provide medical advice. The guidance above is for information only and should be discussed with your medical providers.
Active Surveillance Prostate Cancer Video Chat, April 22nd, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Active Surveillance Prostate Cancer Video Chat, April 8th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Eric- Atlanta 8:00 PM
2026 Prostate Cancer Patients and Caregivers Conference September 18th-20th, 2026 | Early Registration | $30 https://pcri.org/2026-conference
Phil-Toronto 8:03 PM
PCRI mid-year update April 25/26
Ron Jr (Sharon, Pa) 8:28 PM
I live in the Rust Belt, NW Pa, country area – and my Urologist only does Trans-perineal biopsy. I had a hip replacement & it’s the ONLY biopsy I had, and I will get moving forward. Infection would put my total hip at risk!
Albert 9:01 PM
thanks all. Bye, Albert
AnCan – Rick 9:04 PM
Turkey bacon ain’t so bad
AnCan – Rick 9:06 PM
PCPEP study – sign up! https://ancan.org/pcpep-the-prostate-cancer-patient-empowerment-program-040126/
Eric- Atlanta 9:07 PM
Is the PCPEP seminar shared? I had to miss.
